Karydas Daphne sold MLYS
November 13, 2025 · Form 4 insider transaction
Karydas Daphne sold 10,115 shares of Mineralys Therapeutics, Inc. at $45.81 per share, a transaction worth $463.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
10,115
Price
$45.81
Total value
$463.4K
InsiderKarydas Daphne
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 13, 2025
Filing dateNovember 13, 2025
Shares owned after4,885
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $45.19 to $46.18. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.